Antagonistic activity of autosimbionts А. viridans, B. subtilis and their probiotic association to conditionally microflora.

Authors

  • D. A. Stepansky

DOI:

https://doi.org/10.26641/2307-0404.2015.1.40232

Keywords:

autosimbionts, antagonist activity, Aerococcus

Abstract

In this research the data on examination of antagonist qualities of bioassotiantes A. viridans and strain B. subtilis 3 towards pathogenic and opportunistic pathogenic microflora isolated from oropharynx and nasopharynx of children who were in contact with patients with pulmonary tuberculosis (MBT +) are submitted. The expressed antagonist activity of autosimbionts A. viridans towards pathogenic and opportunistic pathogenic microflora was shown. Common antagonist activity of A. viridans (k) N 1 and B. subtilis 3 towards diverse strains of test-cultures is 1,5-2 times higher, than separate antagonist activity of A. viridans (k) №1 and B. subtilis 3. Received research data showed the possibility of continuing work on development of probiotic associations, that contain representatives of normal microflora - bioassociants A. viridans and probiotic strains B. subtilis 3 with broadspectrum of antagonistic activity in relation to the various groups of bacterium.

Author Biography

D. A. Stepansky

SE "Dnipropetrovsk medical academy of Health Ministry of Ukraine"
Department of Microbiology, virology, immunology and epidemiology
Dzerzhinsky str., 9, Dnipropetrovsk, 49044, Ukraine

References

Kremenchutskiy GN, Ryzhenko SA, Volyanskiy AYu. [A-bacterin in the treatment and prevention of in¬flam¬matory processes]. Dnepropetrovsk: Porogi. 2000:150. Russian. 2. Kremenchutskiy GN. [Biological features of A-bacterin]. Medichnі perspektivi. 2001;6(3):90-97. Russian. 3. Kremenchuts'kiy GM. [Culture media for de¬tection of N202, produced by microorga¬nisms].Aktual'nі pitannya іnfektsіynoї patologії. 1983;18. Ukrainian. 4. Kremenchutskiy GN, Ryzhenko SA, Val'chuk SI. [The role of micro ecology of the human body and the prin¬ciples of correction]. Dnepropetrovsk: Porogi. 2003;230. Russian. 5. Lakin GF. [Biometrics]. M. 1990;52. Russian. 6. Lelyak AA, Shternshis MV. [Antagonistic poten¬tial of Siberian strains of Bacillus spp. against pathogens of animals and plants]. Vestnik Tomskogo gosu¬darstvennogo universiteta. Biologiya. 2014;1(25): 42–55. Russian. 7. Kremenchutskiy GN, Yurgel' LG, Sharun OV, Stepans'kiy DO. [Methods for isolation and identification of gram-positive catalaze-negative cocci: guidelines]. K. 2009;19. Ukrainian. 8. About the unification of microbiological methods of research used in clinical-diagnostic laboratories of medical institutions: the Order of Ministry of health USSR № 535 from 22.04.1885. Russian. 9. Ryzhenko SA. [A new probiotic А-bacterin]. Dnepropetrovsk: Porogi. 2001;252. Russian. 10. Michail S, Sylvester F, Fuchs G, Issenman R. Clinical efficacy of probiotics: review of the evidence with focus on children. J. Pediatr. Gastroenterol. Nutr. 2006;43(4):550-7. 11. Abu-Raddad LJ. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proceedings National Acad. Science. 2009;106(33):13980–5. 12. Stein T. Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol. Microbiol. 2005;56:845–57.

Downloads

Published

2015-03-16

How to Cite

1.
Stepansky DA. Antagonistic activity of autosimbionts А. viridans, B. subtilis and their probiotic association to conditionally microflora. Med. perspekt. [Internet]. 2015Mar.16 [cited 2024Apr.27];20(1):14-21. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/40232

Issue

Section

THEORETICAL MEDICINE